Search
Hydroxyprogesterone caproate
go.drugbank.com/drugs/DB06789ApprovedIt is an ester derivative of 17α-hydroxyprogesterone formed from caproic acid (hexanoic acid). … In April 2023, the FDA withdrew its approval of Makena and its generics given an unfavorable risk-to-benefit assessment.[L46113]
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C19 InducersSynonyms: Caproato de hidroxiprogesteronaBosutinib
go.drugbank.com/drugs/DB06616ApprovedInvestigationalPhiladelphia chromosome is a hallmark of CML due to the reciprocal translocation t(9;22)(q34;q11), resulting in a BCR-ABL fusion protein. … -alkoxy-3-quinolinecarbonitrile that functions as a potent, dual SRC and ABL tyrosine kinase inhibitor indicated for chronic myelogenous leukemia (CML), specifically Philadelphia chromosome-positive (Ph
Categories: P-glycoprotein substrates, Cytochrome P-450 SubstratesProducts: BOSUTINIB DR. REDDY?SOxidronic acid
go.drugbank.com/drugs/DB14159ApprovedSynonyms: HMD-PProducts: OSTEOCIS KIT PARA PREPARACIÓNDE OXIDRONATO DE TECNECIO ( 99M TC)Rilpivirine
go.drugbank.com/drugs/DB08864ApprovedInvestigational[L31193] While previously administered once-monthly only, this combination product was granted FDA approval for dosing every two months on February 01, 2022 [L40084] and without the need for an oral lead-in
Categories: P-glycoprotein inhibitors, Cytochrome P-450 SubstratesProducts: REKAMBYS® 300 MG/ML SUSPENSIÓN INYECTABLE DE LIBERACIÓN PROLONGADARabeprazole
go.drugbank.com/drugs/DB01129ApprovedInvestigationalRabeprazole is an antiulcer drug in the class of proton pump inhibitors. It is a prodrug - in the acid environment of the parietal cells it turns into active sulphenamide form.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 InducersProducts: Rabeprazole Sodium DR, Raberprazole Sodium D/rHydrotalcite
go.drugbank.com/drugs/DB13322ApprovedInvestigationalWithdrawnProducts: ALKA - SELTZER RA REGULADOR DE ACIDEZ - SUSPENSION, ALKA SELTZER RA REGULADOR DE ACIDEZ TABLETAS MASTICABLESAcetaminophen
go.drugbank.com/drugs/DB00316ApprovedInvestigational[L5783] Due to the possibility of fatal overdose and liver failure associated with the incorrect use of acetaminophen, it is important to follow current and available national and manufacturer dosing guidelines … [L5786,L5789,L4396] On September 22, 2025, the US FDA initiated a labeling change for acetaminophen products suggesting that the use of acetaminophen by pregnant women may be associated with an increased
Synonyms: p-acetamidophenol, p-acetaminophenolInternational brands: Oraphen-PDGlycopyrronium
go.drugbank.com/drugs/DB00986ApprovedInvestigationalVet approved[A233535,A233540] Early research into glycopyrronium use was for its indication as an adjunct therapy in the treatment of peptic ulcers.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 SubstratesProducts: Glyrx-PF, GLYCO-PVecuronium
go.drugbank.com/drugs/DB01339ApprovedInvestigationalMonoquaternary homolog of pancuronium. A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for el...
Categories: P-glycoprotein substratesProducts: BROMURO DE VECURONIO 10MG/VIAL, BROMURO DE VECURONIO 4 MG/VIAL POLVO LIOFILIZADO PARA RECONSTITUIR A SOLUCION INYECTABLE